Enanta Pharmaceuticals Stock In The News

ENTA Stock  USD 17.46  0.93  5.63%   
The tone or emotional content of news articles related to Enanta Pharmaceuticals can affect its prices. Positive news sentiment can lead to an increase in demand for Enanta Pharmaceuticals' stock, while negative news sentiment can lead to a decrease in demand. Our overall analysis of Enanta Pharmaceuticals' news coverage and content from conventional and social sources shows investors' bearish mood towards Enanta Pharmaceuticals. The specific impact of Enanta Pharmaceuticals news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Enanta Pharmaceuticals' overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Enanta Pharmaceuticals headlines in addition to utilizing other, more conventional financial analysis modules. Check out Enanta Pharmaceuticals Backtesting and Enanta Pharmaceuticals Hype Analysis.
For information on how to trade Enanta Stock refer to our How to Trade Enanta Stock guide.

Enanta Pharmaceuticals Today Top News and Investor Outlook

Yahoo News
Strength Seen in Enanta Pharmaceuticals (ENTA): Can Its 13.8% Jump Turn into More Strength?
https://finance.yahoo.com/news/strength-seen-enanta-pharmaceuticals-enta-080900557.html
 Bullish
Yahoo News
Enanta Pharmaceuticals to Provide Update...
https://finance.yahoo.com/news/enanta-pharmaceuticals-updates-research-development-120000343.html
 Neutral
Yahoo News
Enanta Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
https://finance.yahoo.com/news/enanta-pharmaceuticals-present-42nd-annual-120000670.html
 Neutral
Yahoo News
The Zacks Analyst Blog Highlights Enanta, OneConnect Financial, KNOT Offshore, Hippo Holdings and H World
https://finance.yahoo.com/news/zacks-analyst-blog-highlights-enanta-110000227.html
 Bullish
Yahoo News
Insider Sell Alert: Director Terry Vance Sells 15,295 Shares of Enanta Pharmaceuticals Inc (ENTA)
https://finance.yahoo.com/news/insider-sell-alert-director-terry-100113562.html
 Bullish
Yahoo News
Wall Street Analysts Predict a 108.12% Upside in Enanta Pharmaceuticals (ENTA): Here's What You Should Know
https://finance.yahoo.com/news/wall-street-analysts-predict-108-145509665.html
 Bullish
Yahoo News
How Much Upside is Left in Enanta Pharmaceuticals (ENTA)? Wall Street Analysts Think 88.23%
https://finance.yahoo.com/news/much-upside-left-enanta-pharmaceuticals-145516101.html
 Bullish
Yahoo News
Enanta Pharmaceuticals to Participate at Evercore ISI HealthCONx Conference
https://finance.yahoo.com/news/enanta-pharmaceuticals-participate-evercore-isi-120000969.html
 Neutral
Yahoo News
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Q4 2023 Earnings Call Transcript
https://finance.yahoo.com/news/enanta-pharmaceuticals-inc-nasdaq-enta-134631093.html
 Bullish
Yahoo News
Q4 2023 Enanta Pharmaceuticals Inc Earnings Call
https://finance.yahoo.com/news/q4-2023-enanta-pharmaceuticals-inc-121858027.html
 Bullish

Enanta Pharmaceuticals Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Enanta and other traded companies coverage. We help investors stay connected with Enanta headlines for the 29th of March to make an informed investment decision based on correlating the impacts of news items on Enanta Stock performance. Please note that trading solely based on the Enanta Pharmaceuticals hype is not for everyone as timely availability and quick action are needed to avoid losses.
Enanta Pharmaceuticals' linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Enanta Pharmaceuticals investors visualize upcoming and past events in order to time the market based on Enanta Pharmaceuticals noise-free hype analysis.
Enanta Pharmaceuticals stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Enanta earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Enanta Pharmaceuticals that are available to investors today. That information is available publicly through Enanta media outlets and privately through word of mouth or via Enanta internal channels. However, regardless of the origin, that massive amount of Enanta data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Enanta Pharmaceuticals news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Enanta Pharmaceuticals relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Enanta Pharmaceuticals' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Enanta Pharmaceuticals alpha.

Enanta Largest EPS Surprises

Earnings surprises can significantly impact Enanta Pharmaceuticals' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2016-08-08
2016-06-30-0.09-0.060.0333 
2013-11-25
2013-09-30-0.29-0.250.0413 
2016-11-21
2016-09-30-0.14-0.090.0535 
2015-08-06
2015-06-300.190.13-0.0631 
2014-11-24
2014-09-30-0.33-0.270.0618 
2018-05-08
2018-03-310.530.610.0815 
View All Earnings Estimates

Enanta Pharmaceuticals Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Enanta Pharmaceuticals Stock. Current markets are strongly bullish. About 72% of major world exchanges and indexes are currently up. See today's market update for more information.
Google News at Macroaxis
25th of March 2024
Brokerages Set Enanta Pharmaceuticals, Inc. PT at 19.33 - MarketBeat
at news.google.com 
Google News at Macroaxis
19th of March 2024
Walleye Capital LLC Boosts Stock Position in Enanta Pharmaceuticals, Inc. - Defense World
at news.google.com 
Google News at Macroaxis
15th of March 2024
Jacobs Levy Equity Management Inc. Sells 1697 Shares of Enanta Pharmaceuticals, Inc. - Def...
at news.google.com 
businesswire News
6th of March 2024
Enanta Pharmaceuticals to Participate at Leerink Partners Global Biopharma Conference
at businesswire.com 
news
5th of March 2024
Short Interest in Enanta Pharmaceuticals, Inc. Rises By 20.1
at thelincolnianonline.com 
Macroaxis News
26th of February 2024
Acquisition by Nathaniel Gardiner of 5187 shares of Enanta Pharmaceuticals at 8.99 subject...
at MacroaxisInsider 
insidermonkey News
8th of February 2024
Enanta Pharmaceuticals, Inc. Q1 2024 Earnings Call Transcript
at insidermonkey.com 
Yahoo News
7th of February 2024
Enanta Pharmaceuticals Fiscal Q1 Earnings Snapshot
at finance.yahoo.com 
businesswire News
4th of January 2024
Enanta Pharmaceuticals to Provide Updates on its Research and Development Programs and 202...
at businesswire.com 

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Enanta Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Enanta Pharmaceuticals' short interest history, or implied volatility extrapolated from Enanta Pharmaceuticals options trading.
When determining whether Enanta Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Enanta Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Enanta Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Enanta Pharmaceuticals Stock:
Check out Enanta Pharmaceuticals Backtesting and Enanta Pharmaceuticals Hype Analysis.
For information on how to trade Enanta Stock refer to our How to Trade Enanta Stock guide.
You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Complementary Tools for Enanta Stock analysis

When running Enanta Pharmaceuticals' price analysis, check to measure Enanta Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enanta Pharmaceuticals is operating at the current time. Most of Enanta Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Enanta Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enanta Pharmaceuticals' price. Additionally, you may evaluate how the addition of Enanta Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Money Managers
Screen money managers from public funds and ETFs managed around the world
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Is Enanta Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Enanta Pharmaceuticals. If investors know Enanta will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Enanta Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.66)
Earnings Share
(6.57)
Revenue Per Share
3.5
Quarterly Revenue Growth
(0.24)
Return On Assets
(0.23)
The market value of Enanta Pharmaceuticals is measured differently than its book value, which is the value of Enanta that is recorded on the company's balance sheet. Investors also form their own opinion of Enanta Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Enanta Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Enanta Pharmaceuticals' market value can be influenced by many factors that don't directly affect Enanta Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Enanta Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Enanta Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Enanta Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.